B
BioCardia, Inc. (BCDA)
NCM – Real vaqt narxi. Valyuta: USD
1.20
+0.11 (10.09%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.15
-0.05 (-4.17%)
Bozordan keyin: Jun 26, 2026, 7:57 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.20
+0.11 (10.09%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.15
-0.05 (-4.17%)
Bozordan keyin: Jun 26, 2026, 7:57 PM EDT
BioCardia, Inc., klinik rivojlanish bosqichidagi regenerativ tibbiyot kompaniyasi, Amerika Qo'shma Shtatlarida yurak-qon tomir va o'pka kasalliklari uchun hujayrali va hujayradan olingan terapevtik vositalarni ishlab chiqadi. Kompaniyaning asosiy mahsulot nomzodi CardiAMP hisoblanadi, bu esa qisqartirilgan ejeksiyon fraktsiyasi bilan ishemik yurak etishmovchiligi va surunkali miokard ishemiyasidan kelib chiqqan refrakter stenokardiyani davolash uchun III bosqich klinik sinovdan o'tayotgan avtolog mononuklear hujayra terapiyasi tizimidir. Kompaniya, shuningdek, ishemik yurak etishmovchiligi uchun II bosqichda bo'lgan allogen mezenximal ildiz hujayra terapiyasi CardiALLO; allogen hujayra terapiyasi platformasi; va o'tkir respirator distress sindromi uchun allogen mezenximal ildiz hujayra terapiyasi PulmALLOni taqdim etadi. Bundan tashqari, kompaniya biologik vositalarni yurakka minimal invaziv maqsadli etkazib berish uchun Helix bioterapevtik etkazib berish tizimini; fusion tasvirlash uchun Heart3D; hamda morph DNA va avance boshqariladigan introduserlarni taklif etadi. Kompaniya Biomet Biologics, LLC bilan litsenziya va distribyutorlik shartnomasiga ega. BioCardia, Inc. Kaliforniyaning Sunnyvale shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Peter A. Altman Ph.D. | CEO, President & Director |
| Mr. David McClung | Chief Financial Officer |
| Mr. Edward M. Gillis | Senior Vice President of Devices |
| Ms. Miranda Peto Benvenuti | Investor Relations Executive |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-18 | 8-K | bcda20260617_8k.htm |
| 2026-06-12 | 8-K | bcda20260612_8k.htm |
| 2026-06-08 | 8-K | bcda20260607_8k.htm |
| 2026-06-05 | 8-K | bcda20260605d_8k.htm |
| 2026-05-28 | 8-K | bcda20260528_8k.htm |
| 2026-05-21 | 8-K | bcda20260520_8k.htm |
| 2026-05-15 | 8-K | bcda20260515_8k.htm |
| 2026-05-15 | 10-Q | bcda20260331_10q.htm |
| 2026-05-08 | 8-K | bcda20260508_8k.htm |
| 2026-04-28 | 8-K | bcda20260428_8k.htm |